CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale Chief Financial Officer sold 3,763 shares at an average $9.86 ($37,090)
- 4 Open-market sale EVP, Head of R&D sold 2,221 shares at $9.86 ($21,890)
- 4 Grant or award Chief Commercial Officer acquired 45,533 shares (grant or award)
- 4 Open-market sale President and CEO sold 8,828 shares at $9.86 ($87,009)
- 4 Open-market sale SVP, GC & Secretary sold 2,577 shares at an average $9.86 ($25,400)
- 4 Open-market sale EVP, Head of R&D sold 5,000 shares at $16.00 ($80,000)
- 4 Open-market sale Chief Financial Officer sold 2,496 shares at $14.46 ($36,096)
- 4 Open-market sale EVP, Head of R&D sold 5,000 shares at $16.01 ($80,050)
- 4 Open-market sale EVP, Head of R&D sold 5,000 shares at $17.94 ($89,689)
- 4 Open-market sale President and CEO sold 8,402 shares at $17.12 ($143,816)
- 4 Open-market sale Chief Operations Officer sold 3,332 shares at $17.12 ($57,034)
- 4 Open-market sale SVP, GC & Secretary sold 2,124 shares at $17.12 ($36,356)
- 4 Open-market sale Chief Financial Officer sold 3,655 shares at $17.12 ($62,562)
- 4 Open-market sale EVP, Head of R&D sold 2,199 shares at $17.12 ($37,640)
- 4 Open-market sale Chief Operations Officer sold 7,000 shares at $17.71 ($124,004)
- 4 Open-market sale Director sold 13,354 shares at $19.50 ($260,403)
- 4 Open-market sale EVP, Head of R&D sold 5,000 shares at $16.41 ($82,050)
- 4 Open-market sale Chief Operations Officer sold 10,500 shares at $17.00 ($178,500)
- 4 Open-market sale Chief Operations Officer sold 3,116 shares at $15.61 ($48,647)
- 4 Open-market sale Chief Operations Officer sold 3,500 shares at $15.00 ($52,500)
Page 8 of 33 · 644 filings